Cargando…

伊立替康二线治疗难治性复发小细胞肺癌的疗效分析

BACKGROUND AND OBJECTIVE: Among malignant tumors, lung cancer has the highest mortality rate. Small cell lung cancer (SCLC) is a kind of malignant lung cancer. Its doubling time is very fast. Patients are prone to drug resistance during treatment, and their condition often deteriorates rapidly after...

Descripción completa

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 中国肺癌杂志编辑部 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8143965/
https://www.ncbi.nlm.nih.gov/pubmed/33819966
http://dx.doi.org/10.3779/j.issn.1009-3419.2021.103.04